InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（30 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
30
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Lewis William, 董事长兼首席执行官. Director active across 4 companies, notably INSMED Inc. Cumulatively, 85 disclosures have been published. Breakdown: 1 buy · 30 sells. Total volume traded: €9.6m. Activity tracked since 15 May 2021. The latest transaction was disclosed on 23 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Lewis William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报85 总计
6,260 股@ US$30.460.0008% mcap2.4% 占其流量Common StockSEC:0001402051-26-000042:0
4,440 股@ US$17.160.0003% mcap0.9% 占其流量Common StockSEC:0001402051-26-000042:1
4,828 股@ US$105.620.0022% mcap6.3% 占其流量Common StockSEC:0001402051-26-000042:2
5,872 股@ US$106.430.0027% mcap7.7% 占其流量Common StockSEC:0001402051-26-000042:3
6,259 股@ US$30.460.0007% mcap4.5% 占其流量Common StockSEC:0001402051-26-000040:0
4,440 股@ US$17.160.0003% mcap1.8% 占其流量Common StockSEC:0001402051-26-000040:1
5,005 股@ US$116.550.0023% mcap13.9% 占其流量Common StockSEC:0001402051-26-000040:2
2,335 股@ US$117.620.0011% mcap6.5% 占其流量Common StockSEC:0001402051-26-000040:3
3,359 股@ US$118.520.0016% mcap9.5% 占其流量Common StockSEC:0001402051-26-000040:4
12,518 股Common StockSEC:0001402051-26-000038:0
8,880 股Common StockSEC:0001402051-26-000038:1
12,091 股Common StockSEC:0001402051-26-000038:2
1,836 股Common StockSEC:0001402051-26-000038:3
3,723 股Common StockSEC:0001402051-26-000038:4
2,456 股Common StockSEC:0001402051-26-000038:5
1,292 股Common StockSEC:0001402051-26-000038:6
13,283 股@ US$116.180.0035% mcap51.0% 占其流量Common StockSEC:0001402051-26-000028:0
6,259 股@ US$30.460.0008% mcap3.9% 占其流量Common StockSEC:0001402051-26-000024:0
4,440 股@ US$17.160.0003% mcap1.6% 占其流量Common StockSEC:0001402051-26-000024:1
2,246 股@ US$142.990.0013% mcap6.6% 占其流量Common StockSEC:0001402051-26-000024:2
5,373 股@ US$143.810.0031% mcap15.9% 占其流量Common StockSEC:0001402051-26-000024:3
2,255 股@ US$144.660.0013% mcap6.7% 占其流量Common StockSEC:0001402051-26-000024:4
825 股@ US$145.790.0005% mcap2.5% 占其流量Common StockSEC:0001402051-26-000024:5
6,259 股@ US$30.462.8% 占其流量Common StockSEC:0001402051-26-000022:0
4,440 股@ US$17.161.1% 占其流量Common StockSEC:0001402051-26-000022:1
85 条申报中的 25 条
About Lewis William
Lewis William is President and Chief Executive Officer. He has 81 filings in total, and in the sampled recent filings from 2016-02-03 to 2026-07-10, there were no purchases and EUR 8594935 of sales, with the most common transaction nature listed as option exercise. His recent filings concern INSMED Inc, where he is Chair and CEO, and NewAmsterdam Pharma Co N.V., where he is Director.
